Abstract:Background Numerous GWAS studies of Alzheimer’s disease (AD) have identified over 70 AD risk variants using SNP‐based genotyping or sequencing data. Recently, a new whole‐genome tiling (WGT) representation of whole‐genome sequencing (WGS) data has been proposed to enable an innovative definition of an individual’s genome; this WGT representation can support supervised and unsupervised machine learning. In this study, we perform a new AD GWAS study on the WGT representation of the ADNI WGS data. Methods The detailed description, genome tiling pipeline, and a publicly available example of WGT data are available at: https://curii.co/su92l‐j7d0g‐swtofxa2rct8495 . In our analysis, we first performed quality control, imputation, and one‐hot encoding of tile variants (Fig. 1). Then, for each genome tile, we used the likelihood ratio test to compare two logistic regression models to get a single p‐value, where a full model used the tile variants and covariates to predict disease status, and a null model used only covariates including age, sex, education, APOE4, and first 20 PCs. Participants included 1,504 subjects (1,032 cases and 472 controls). In comparison, set‐based GWAS analysis was performed using PLINK 1.9 on ADNI SNP‐based WGS data. Results 8,560,743 tiles passed the QC process and were included in our analysis. The likelihood ratio test yielded 35,582 significant tiles with Bonferroni correction. A set‐based GWAS comparative study among all significant tiles using SNP‐based WGS data identified 1,535 sets with at least one significant SNP variant. Among 1,535 sets, 1,066 sets passed uncorrected p≤0.05; 115 sets passed p≤0.005; and 15 sets passed p≤0.0005 (Fig. 2). Conclusions Our initial investigation of the tiling data shows that the WGT representation has promising power for identifying significant tiles that cannot be detected using the SNP representation. Complementary to the genotype values examined in traditional SNP analysis, the WGT analysis focuses on examining the haplotype variants within each tile and can capture the interaction pattern among SNPs within the haplotype. This initial AD GWAS study on WGT data demonstrates the promise of the tile representation for revealing novel genetic risk and protective factors in AD.

Discovering Genetic Signatures Associated with Alzheimer's Disease in Tiled Whole Genome Sequence Data: Results from the Artificial Intelligence for Alzheimer's Disease (AI4AD) Consortium

Genetic association study of Alzheimer’s disease through whole genome tiling analysis

Transcriptome-guided Amyloid Imaging Genetic Analysis Via a Novel Structured Sparse Learning Algorithm.

Mining Outcome-Relevant Brain Imaging Genetic Associations Via Three-Way Sparse Canonical Correlation Analysis in Alzheimer'S Disease

Mapping the Genetic-Imaging-Clinical Pathway with Applications to Alzheimer's Disease

LD-informed deep learning for Alzheimer's gene loci detection using WGS data

Alzheimer's Disease Sequencing Project Release 4 Whole Genome Sequencing Dataset

Genome wide association neural networks (GWANN) identify genes linked to family history of Alzheimer’s disease

Identifying Genetic Risk Factors for Alzheimer's Disease Via Shared Tree-Guided Feature Learning Across Multiple Tasks.

Exploring Imaging Genetic Markers of Alzheimer's Disease Based on a Novel Nonlinear Correlation Analysis Algorithm

Revealing Alzheimer’s Disease Genes Spectrum in the Whole-Genome by Machine Learning

Association of Common and Rare Variants with Alzheimer's Disease in over 13,000 Diverse Individuals with Whole-Genome Sequencing from the Alzheimer's Disease Sequencing Project

Genetic and Clinical Correlates of Two Neuroanatomical AI Dimensions in the Alzheimer’s Disease Continuum

Discovery of Genetic Biomarkers for Alzheimer's Disease Using Adaptive Convolutional Neural Networks Ensemble and Genome-Wide Association Studies

Identification of feature genes and pathways for Alzheimer's disease via WGCNA and LASSO regression

Genetic and clinical correlates of two neuroanatomical AI dimensions in the Alzheimer's disease continuum

System-Level Analysis of Alzheimer's Disease Prioritizes Candidate Genes for Neurodegeneration

Genome-wide prediction and integrative functional characterization of Alzheimer’s disease-associated genes

Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease

The Mount Sinai Cohort of Large-Scale Genomic, Transcriptomic and Proteomic Data in Alzheimer's Disease

Bioinformatics investigation on blood-based gene expressions of Alzheimer's disease revealed ORAI2 gene biomarker susceptibility: An explainable artificial intelligence-based approach